120 related articles for article (PubMed ID: 37526986)
21. Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway.
Chen DY; Fabrizio JA; Wilkins SE; Dave KA; Gorman JJ; Gleadle JM; Fleming SB; Peet DJ; Mercer AA
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795413
[TBL] [Abstract][Full Text] [Related]
22. The conservation and functionality of the oxygen-sensing enzyme Factor Inhibiting HIF (FIH) in non-vertebrates.
Hampton-Smith RJ; Davenport BA; Nagarajan Y; Peet DJ
PLoS One; 2019; 14(4):e0216134. PubMed ID: 31034531
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor 1 (HIF-1) pathway.
Semenza GL
Sci STKE; 2007 Oct; 2007(407):cm8. PubMed ID: 17925579
[TBL] [Abstract][Full Text] [Related]
24. Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).
Cockman ME; Lancaster DE; Stolze IP; Hewitson KS; McDonough MA; Coleman ML; Coles CH; Yu X; Hay RT; Ley SC; Pugh CW; Oldham NJ; Masson N; Schofield CJ; Ratcliffe PJ
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14767-72. PubMed ID: 17003112
[TBL] [Abstract][Full Text] [Related]
25. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha.
Lee YM; Lim JH; Chun YS; Moon HE; Lee MK; Huang LE; Park JW
Carcinogenesis; 2009 Oct; 30(10):1768-75. PubMed ID: 19696166
[TBL] [Abstract][Full Text] [Related]
26. Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.
Cockman ME; Webb JD; Kramer HB; Kessler BM; Ratcliffe PJ
Mol Cell Proteomics; 2009 Mar; 8(3):535-46. PubMed ID: 18936059
[TBL] [Abstract][Full Text] [Related]
27. Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha.
Shin DH; Li SH; Yang SW; Lee BL; Lee MK; Park JW
FEBS J; 2009 Jul; 276(13):3470-80. PubMed ID: 19456861
[TBL] [Abstract][Full Text] [Related]
28. FIH-dependent asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.
Cockman ME; Webb JD; Ratcliffe PJ
Ann N Y Acad Sci; 2009 Oct; 1177():9-18. PubMed ID: 19845602
[TBL] [Abstract][Full Text] [Related]
29. Siah-1 facilitates ubiquitination and degradation of factor inhibiting HIF-1alpha (FIH).
Fukuba H; Yamashita H; Nagano Y; Jin HG; Hiji M; Ohtsuki T; Takahashi T; Kohriyama T; Matsumoto M
Biochem Biophys Res Commun; 2007 Feb; 353(2):324-9. PubMed ID: 17188242
[TBL] [Abstract][Full Text] [Related]
30. Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH).
Flagg SC; Martin CB; Taabazuing CY; Holmes BE; Knapp MJ
J Inorg Biochem; 2012 Aug; 113():25-30. PubMed ID: 22687491
[TBL] [Abstract][Full Text] [Related]
31. Signalling cross talk of the HIF system: involvement of the FIH protein.
Coleman ML; Ratcliffe PJ
Curr Pharm Des; 2009; 15(33):3904-7. PubMed ID: 19671041
[TBL] [Abstract][Full Text] [Related]
32. Kinetic Studies of the Hydrogen Atom Transfer in a Hypoxia-Sensing Enzyme, FIH-1: KIE and O
Mingroni MA; Knapp MJ
Biochemistry; 2021 Nov; 60(44):3315-3322. PubMed ID: 34714626
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy.
Wu Y; Li Z; McDonough MA; Schofield CJ; Zhang X
J Med Chem; 2021 Jun; 64(11):7189-7209. PubMed ID: 34029087
[TBL] [Abstract][Full Text] [Related]
34. Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau.
Lee C; Kim SJ; Jeong DG; Lee SM; Ryu SE
J Biol Chem; 2003 Feb; 278(9):7558-63. PubMed ID: 12482756
[TBL] [Abstract][Full Text] [Related]
35. FIH permits NAA10 to catalyze the oxygen-dependent lysyl-acetylation of HIF-1α.
Kang J; Chun YS; Huh J; Park JW
Redox Biol; 2018 Oct; 19():364-374. PubMed ID: 30237125
[TBL] [Abstract][Full Text] [Related]
36. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.
Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
Breast Cancer Res; 2007; 9(6):R89. PubMed ID: 18096060
[TBL] [Abstract][Full Text] [Related]
37. Asparagine and aspartate hydroxylation of the cytoskeletal ankyrin family is catalyzed by factor-inhibiting hypoxia-inducible factor.
Yang M; Ge W; Chowdhury R; Claridge TD; Kramer HB; Schmierer B; McDonough MA; Gong L; Kessler BM; Ratcliffe PJ; Coleman ML; Schofield CJ
J Biol Chem; 2011 Mar; 286(9):7648-60. PubMed ID: 21177872
[TBL] [Abstract][Full Text] [Related]
38. Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
Strowitzki MJ; Cummins EP; Taylor CT
Cells; 2019 Apr; 8(5):. PubMed ID: 31035491
[TBL] [Abstract][Full Text] [Related]
39. Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1.
Shin DH; Chun YS; Lee DS; Huang LE; Park JW
Blood; 2008 Mar; 111(6):3131-6. PubMed ID: 18174379
[TBL] [Abstract][Full Text] [Related]
40. Measurement of kinetic isotope effects on peptide hydroxylation using MALDI-MS.
Mingroni MA; Chaplin Momaney V; Barlow AN; Jaen Maisonet I; Knapp MJ
Methods Enzymol; 2023; 679():363-380. PubMed ID: 36682871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
